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Objective: This study aimed to assess the feasibility and acceptability of Lee Silverman Voice Treatment
(LSVT) provided via Skype for patients with hereditary ataxia.
Background: Ataxic dysarthria due to hereditary ataxia affects all levels of speech production such as breath
support, voice quality, articulation and prosody and can lead to signi cant communication impairment. Yet
there are currently no evidence based speech treatments available for people with this disease. As a result,
patients are often not offered treatment despite signi cant impact on communication related quality of life.
This study investigated whether LSVT, a speech treatment focusing on increasing loudness, can improve
communication in these speakers.
Method: 20 patients were recruited to the study and 19 completed treatment. Of these 17 had been
diagnosed with Friedreich’s ataxia, one with SCA6, one with SPG7, and one with unspeci ed cerebellar
ataxia. An extended version of LSVT, consisting of 2 sessions a week over 8 weeks was provided via Skype.
Two baseline (2 weeks apart) and two post-treatment measures (immediately following and 8 weeks after
treatment) were collected. Materials included a range of speech tasks, questionnaires and a patient
interview. Pre- and post-treatment comparisons focused on acoustic and perceptual speech parameters,
including voice quality, breath support, intelligibility and naturalness, as well as impact and communication
participation.
Results: Results indicate improvements in breath support and in voice quality for sustained vowels and
connected speech, both for acoustic and perceptual measures. Most of these improvements were maintained
longer term. No changes were evident for intelligibility or naturalness, however, patient reported outcomes
were positive for most participants, both in the speech and psycho-social domains. There were no negative
reports with regard to fatigue, and the majority of patients preferred Skype delivery over face to face
provision.
Conclusion: The study suggests, along with a recent pilot study by Vogel et al. (2019) that speech treatment
can have a bene cial impact on communication in patients with hereditary ataxia and should therefore be
provided by clinicians.
This study has also been presented at the International Ataxia Research Conference, 14-16 November 2019,
Washington DC, and the 2020 Motor Speech Conference, 19-23 February 2020, Santa Barbara, California
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